Immune Checkpoint Blockade Combined with AbnobaViscum Therapy Is Linked to Improved Survival in Advanced or Metastatic Non-Small-Cell Lung Cancer Patients: A Registry Study in Accordance with the ESMO Guidance for Reporting Real-World Evidence.

Research Projects
Organizational Units
Journal Issue
Description
Abstract
Table of contents
Keywords
Citation
Full text
Document Viewer
Select a file to preview:
Can't see the file? Try reloading